Global Biobanking Equipment Market Continues to Grow as Brooks Life Sciences launches BioStore IIIv, an automated next-generation alternative to manual -80°C mechanical freezers
Biobanking is a type of biorepository that stores biological samples for research purposes. Over the years biobanks have become a key resource in medical research and have supported contemporary research activities such as personalized medicine and genomics. Generally, biobanks can offer access to researchers to data representing a vast pool of population, which also has sparked questions on research ethics and privacy. Mostly, biobanks have been used in human genetics research.
Growing prevalence of chronic
diseases is expected to drive growth of the global biobanking equipment market.
According to the Centers for Disease Control and Prevention (CDC), in the U.S.,
in 2020, around 108 million people have hypertension, which is defined as
systolic blood pressure. According to the World Health Organization (WHO), in
2016, around 251 million cases of COPD were diagnosed across the globe, while
around 3.17 million deaths were caused due to COPD in 2015. According to the
Cystic Fibrosis Foundation (CFF), over 1,000 new cases of cystic fibrosis are
diagnosed each year in the U.S. Growing prevalence of such chronic diseases has
increased the demand for biobanking equipment significantly. The primary airway
cell biobank (PACB) has been collecting biobanking samples since 2009 and
provides primary airway epithelial cells from normal donors. Thus, these
factors are expected to drive growth of the global biobanking
equipment market. Furthermore, technological advancements in stem cell and
regenerative medicine are expected to propel the global biobanking equipment
market growth in the near future.
However, a stringent regulatory
framework imposed by governing authorities is expected to hamper the global
biobanking equipment market growth in the near future. Among regions, North
America is expected to witness significant growth in the global biobanking
equipment market. This is owing to the presence of robust healthcare
infrastructure in the region. Furthermore, Europe is expected to register a
robust growth rate, owing to growing emphasis on research and development
activities for treatment and diagnosis.
Key companies involved in the global
biobanking equipment market are Becton, Dickinson and Company, Thermo Fisher
Scientific Inc., Bio-Techne Corporation, Stemcell Technologies Inc., Brooks
Automation, Stemcell Technologies Inc., Hamilton Company, QIAGEN N.V., Merck
KGaA, and Lonza Group.
For instance, in August 2020, Brooks
Life Sciences, a subsidiary of Brooks Automation, launched BioStore IIIv, an
automated next-generation alternative to manual -80°C mechanical freezers.
Comments
Post a Comment